SCHEMBL1933458

SCHEMBL1933458

CCCCNC1CCC(NCCCC)CC1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GNAI3 P08754 2/20 0.57
GNAO1 P09471 2/20 0.57
GNAI1 P63096 2/20 0.57
S1PR4 O95977 2/20 0.47
S1PR1 P21453 2/20 0.47
S1PR3 Q99500 2/20 0.47
METAP1 P53582 1/20 0.41
DRD2 P14416 2/20 0.41
DRD3 P35462 2/20 0.41
FUCA1 P04066 1/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
S1PR5 Q9H228 1/20 0.41
CYP2C9 P11712 1/20 0.40
HRH3 Q9Y5N1 1/20 0.40
SPHK1 Q9NYA1 1/20 0.40
CNR1 P21554 2/20 0.40
CNR2 P34972 1/20 0.40
TSHR P16473 1/20 0.39
GBA1 P04062 3/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1678660 1.00
SCHEMBL21089248 0.93 GNAI3 (0.52) GNAI3GNAO1GNAI1S1PR4S1PR1
SCHEMBL530708 0.92
SCHEMBL13999315 0.91 GNAI3 (0.50) GNAI3GNAO1GNAI1S1PR4S1PR1
SCHEMBL24210534 0.90 GNAI3 (0.70) GNAI3GNAO1GNAI1S1PR4S1PR1
SCHEMBL9155873 0.90 GNAI3 (0.70) GNAI3GNAO1GNAI1S1PR4S1PR1
SCHEMBL20746945 0.90 GNAI3 (0.70) GNAI3GNAO1GNAI1S1PR4S1PR1
SCHEMBL1485880 0.90 GNAI3 (0.53) GNAI3GNAO1GNAI1S1PR4S1PR1
SCHEMBL194145 0.90
SCHEMBL31020849 0.90 GNAI3 (0.70) GNAI3GNAO1GNAI1S1PR4S1PR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12624265-B2 Antistatic agent, antistatic composition comprising same, antistatic resin composition comprising same, and molded article thereof ADEKA CORPORATION (JP) 2026-05-12 US disclosed
US-20250163281-A1 THERMOPLASTIC RESIN COMPOSITION FOR FUSED DEPOSITION MODELING, MODELED BODY, AND METHOD FOR PRODUCING SAME ADEKA CORPORATION (JP) 2025-05-22 US disclosed
EP-4484465-A1 THERMOPLASTIC RESIN COMPOSITION FOR FUSED DEPOSITION MODELING, MODELED BODY, AND METHOD FOR PRODUCING SAME ADEKA CORPORATION (JP) 2025-01-01 EP disclosed
CN-118749016-A Thermoplastic resin composition for hot melt lamination molding, molded body, and method for producing the same 株式会社ADEKA 2024-10-08 CN disclosed
WO-2023163017-A1 THERMOPLASTIC RESIN COMPOSITION FOR FUSED DEPOSITION MODELING, MODELED BODY, AND METHOD FOR PRODUCING SAME 株式会社ADEKA 2023-08-31 WO disclosed
EP-3945102-B1 ANTISTATIC AGENT, ANTISTATIC COMPOSITION COMPRISING SAME, ANTISTATIC RESIN COMPOSITION COMPRISING SAME, AND MOLDED ARTICLE THEREOF ADEKA CORP (JP) 2023-08-02 EP disclosed
WO-2023281602-A1 THERMOPLASTIC RESIN COMPOSITION, MOLDED ARTICLE AND PRODUCT 三菱電機株式会社 2023-01-12 WO disclosed
US-20220177757-A1 ANTISTATIC AGENT, ANTISTATIC COMPOSITION COMPRISING SAME, ANTISTATIC RESIN COMPOSITION COMPRISING SAME, AND MOLDED ARTICLE THEREOF ADEKA CORPORATION (JP) 2022-06-09 US disclosed
EP-3945102-A1 ANTISTATIC AGENT, ANTISTATIC COMPOSITION COMPRISING SAME, ANTISTATIC RESIN COMPOSITION COMPRISING SAME, AND MOLDED ARTICLE THEREOF ADEKA CORPORATION (JP) 2022-02-02 EP disclosed
EP-3196273-B1 ANTISTATIC AGENT, ANTISTATIC AGENT COMPOSITION, ANTISTATIC RESIN COMPOSITION, AND MOLDED ARTICLE ADEKA CORP (JP) 2021-06-30 EP disclosed
US-9580545-B2 Antistatic agent, antistatic agent composition, antistatic resin composition, and molded article ADEKA CORPORATION (JP) 2017-02-28 US disclosed
US-20160289375-A1 ANTISTATIC AGENT, ANTISTATIC AGENT COMPOSITION, ANTISTATIC RESIN COMPOSITION, AND MOLDED ARTICLE ADEKA CORPORATION (JP) 2016-10-06 US disclosed
EP-2977424-A1 ANTISTATIC AGENT, ANTISTATIC AGENT COMPOSITION, ANTISTATIC RESIN COMPOSITION, AND MOLDED ARTICLE Adeka Corporation (JP) 2016-01-27 EP disclosed
EP-2949721-A1 ANTISTATIC AGENT, ANTISTATIC AGENT COMPOSITION, ANTISTATIC RESIN COMPOSITION, AND MOLDED BODY Adeka Corporation (JP) 2015-12-02 EP disclosed
US-8080626-B2 Chain extenders ALBEMARLE CORPORATION (US) 2011-12-20 US disclosed
US-7964695-B2 Chain extenders ALBEMARLE CORPORATION (US) 2011-06-21 US disclosed
US-20110137005-A1 Chain Extenders ALBEMARLE CORPORATION (US) 2011-06-09 US disclosed
EP-2078048-A1 DIAMINE CHAIN EXTENDER COMPOSITIONS Albemarle Corporation (US) 2009-07-15 EP disclosed
WO-2008039571-A1 DIAMINE CHAIN EXTENDER COMPOSITIONS ALBEMARLE CORPORATION (US) 2008-04-03 WO disclosed
US-20070270566-A1 Chain Extenders ALBEMARLE CORPORATION (US) 2007-11-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070270566-A1 Chain Extenders DDC, PARG, ODC1 GNAI3 3803/4885GNAO1 4338/4885GNAI1 4112/4885
US-12624265-B2 Antistatic agent, antistatic composition comprising same, antistatic resin composition comprising same, and molded article thereof SORD, SUCLA2, SUCLG1 GNAI3 4879/4885GNAO1 4587/4885GNAI1 4860/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.